Cargando…
Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study
Objective: The aim of this study was to explore the side effects of COVID-19 vaccines among a mixed gender sample of patients on monoclonal antibody biologics (mAbs) in Saudi Arabia. Methods: This was a prospective questionnaire-based cross-sectional study in which adult patients (≥18 years) on mAbs...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231333/ https://www.ncbi.nlm.nih.gov/pubmed/35746586 http://dx.doi.org/10.3390/vaccines10060977 |
_version_ | 1784735311859810304 |
---|---|
author | AlMutairi, Lama T Alalayet, Wesal Y Ata, Sondus I Alenzi, Khalidah A AlRuthia, Yazed |
author_facet | AlMutairi, Lama T Alalayet, Wesal Y Ata, Sondus I Alenzi, Khalidah A AlRuthia, Yazed |
author_sort | AlMutairi, Lama T |
collection | PubMed |
description | Objective: The aim of this study was to explore the side effects of COVID-19 vaccines among a mixed gender sample of patients on monoclonal antibody biologics (mAbs) in Saudi Arabia. Methods: This was a prospective questionnaire-based cross-sectional study in which adult patients (≥18 years) on mAbs who had received at least one dose of COVID-19 vaccine from three tertiary care centers in Saudi Arabia were included. Descriptive statistics and univariate logistic regressions were conducted to present the vaccine side effects and examine the association between the reported side effects and vaccine type. Results: Four-hundred and seventeen patients, with a mean age of 39 years, consented to participate. Approximately 82% and 18% of the participants received Pfizer–BioNTech and Oxford–AstraZeneca vaccines, respectively, and nearly 71% received two doses of the vaccine. Diarrhea (9.59%), fever (51.32%), headache (32.13%), hypotension (13.67%), palpitation (9.11%), and temporary loss of smell (5.28%) were the most commonly reported side effects. Conclusion: COVID-19 vaccines are generally safe for patients treated with mAbs. Future studies should examine the rates of side effects across different COVID-19 vaccines among patients on mAbs using more robust study designs and representative samples. |
format | Online Article Text |
id | pubmed-9231333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-92313332022-06-25 Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study AlMutairi, Lama T Alalayet, Wesal Y Ata, Sondus I Alenzi, Khalidah A AlRuthia, Yazed Vaccines (Basel) Article Objective: The aim of this study was to explore the side effects of COVID-19 vaccines among a mixed gender sample of patients on monoclonal antibody biologics (mAbs) in Saudi Arabia. Methods: This was a prospective questionnaire-based cross-sectional study in which adult patients (≥18 years) on mAbs who had received at least one dose of COVID-19 vaccine from three tertiary care centers in Saudi Arabia were included. Descriptive statistics and univariate logistic regressions were conducted to present the vaccine side effects and examine the association between the reported side effects and vaccine type. Results: Four-hundred and seventeen patients, with a mean age of 39 years, consented to participate. Approximately 82% and 18% of the participants received Pfizer–BioNTech and Oxford–AstraZeneca vaccines, respectively, and nearly 71% received two doses of the vaccine. Diarrhea (9.59%), fever (51.32%), headache (32.13%), hypotension (13.67%), palpitation (9.11%), and temporary loss of smell (5.28%) were the most commonly reported side effects. Conclusion: COVID-19 vaccines are generally safe for patients treated with mAbs. Future studies should examine the rates of side effects across different COVID-19 vaccines among patients on mAbs using more robust study designs and representative samples. MDPI 2022-06-20 /pmc/articles/PMC9231333/ /pubmed/35746586 http://dx.doi.org/10.3390/vaccines10060977 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article AlMutairi, Lama T Alalayet, Wesal Y Ata, Sondus I Alenzi, Khalidah A AlRuthia, Yazed Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study |
title | Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study |
title_full | Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study |
title_fullStr | Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study |
title_full_unstemmed | Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study |
title_short | Self-Reported COVID-19 Vaccines’ Side Effects among Patients Treated with Biological Therapies in Saudi Arabia: A Multicenter Cross-Sectional Study |
title_sort | self-reported covid-19 vaccines’ side effects among patients treated with biological therapies in saudi arabia: a multicenter cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9231333/ https://www.ncbi.nlm.nih.gov/pubmed/35746586 http://dx.doi.org/10.3390/vaccines10060977 |
work_keys_str_mv | AT almutairilamat selfreportedcovid19vaccinessideeffectsamongpatientstreatedwithbiologicaltherapiesinsaudiarabiaamulticentercrosssectionalstudy AT alalayetwesaly selfreportedcovid19vaccinessideeffectsamongpatientstreatedwithbiologicaltherapiesinsaudiarabiaamulticentercrosssectionalstudy AT atasondusi selfreportedcovid19vaccinessideeffectsamongpatientstreatedwithbiologicaltherapiesinsaudiarabiaamulticentercrosssectionalstudy AT alenzikhalidaha selfreportedcovid19vaccinessideeffectsamongpatientstreatedwithbiologicaltherapiesinsaudiarabiaamulticentercrosssectionalstudy AT alruthiayazed selfreportedcovid19vaccinessideeffectsamongpatientstreatedwithbiologicaltherapiesinsaudiarabiaamulticentercrosssectionalstudy |